Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)

In market activity today, Briacell Therapeutics Corp stock opened at $1.31 and closed at $1.25. It traded at a low of $1.24 to a high of $1.31.

Shares dipped -3.85% from the previous day's close of $1.30.

Today across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

A total of 2,650 shares was traded during the session, with total trades of 26. On average, Briacell Therapeutics Corp has traded 4,641 shares over 5 days and 8,246 year-to-date.

The TSX market on the whole today saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $1.18 (July 12,2024). Moreover, in the last 52 weeks, Briacell Therapeutics Corp's shares have plummeted -85.38 percent, while they have plummeted -83.97% year-to-date.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $23.77 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp has an average recommendation of "Strong Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..